Restasis Patent Challenges Must Be Tossed, Tribe Tells PTAB

By Matthew Bultman (September 22, 2017, 5:57 PM EDT) -- The Saint Regis Mohawk Tribe, owner of patents for the best-selling eye drug Restasis following a surprise deal with Allergan PLC, told the Patent Trial and Appeal Board on Friday that challenges to the patents must be tossed and laid out its case for why tribal sovereign immunity shields them from review....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!